Therapeutics Lifecycle SIG

Join us Wednesday for a presentation on the impact of therapeutic inertia on new therapy adoption, plus a discussion on best practices for how telehealth can support new therapies coming to market.

The Therapeutic Lifecycle SIG focuses holistically on the full lifecycle of therapeutic development, from clinical trials to in-market use. Initial work will focus on clinical research, regulatory submission, in-market pharmaceuticals, and connecting research technology solutions to in-market technology solutions.